Bessemer Group Inc Neogenomics Inc Transaction History
Bessemer Group Inc
- $55.8 Billion
- Q1 2025
A detailed history of Bessemer Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Bessemer Group Inc holds 684 shares of NEO stock, worth $6,669. This represents 0.0% of its overall portfolio holdings.
Number of Shares
684
Previous 2,533
73.0%
Holding current value
$6,669
Previous $42,000
85.71%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$192 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$139 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$63.6 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$60.1 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$60 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.23B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...